Background-We explored whether, the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) coronary and abdominal risk scores measured at 18 to 30 years of age and changes in these scores would more strongly predict coronary artery calcium (CAC) and abdominal aortic calcium (AAC) assessed 25 years later, than scores measured 25 years later. Methods and Results-In the Coronary Artery Risk Development in Young Adults (CARDIA) study, 3008 participants had measurements of risk score components at 5-year intervals beginning at 18 to 30 years of age. CAC and AAC were assessed at 43 to 55 years of age. Odds ratios (ORs) for the presence and extent of CAC/AAC per/point higher score and c-statistics for predicting CAC/AAC were calculated. The prevalence of CAC was 28% and AAC was 53%. For each 1 point higher PDAY score, the odds of CAC were higher using baseline scores than year 25 scores (OR, 1.29; 95% confidence interval [CI], 1.25-1.33 versus OR, 1.12; 95% CI, 1.11-1.14). For AAC, ORs at years 0 and 25 were similar (OR, 1.29; 95% CI, 1.24-1.34 versus OR, 1.22; 95% CI, 1.19-1.26). C-statistic for CAC prediction was higher at year 0 than year 25 (0.731 versus 0.705) but similar at years 0 and 25 for AAC (0.665 versus 0.670). ORs for CAC were highest at baseline, and, for AAC, ORs were highest at year 10. Including change in PDAY scores with baseline scores improved prediction. Conclusions-Atherosclerosis risk and change in risk assessed in young adulthood years before subclinical atherosclerosis imaging provide strong prediction of future subclinical atherosclerosis. CAC and AAC reflect chronic risk exposure in addition to risk measured at the time of study.
T he Pathobiological Determinants of Atherosclerosis in
Youth (PDAY) risk scores were developed to predict the likelihood of having advanced atherosclerosis in the coronary arteries or abdominal aorta by relating risk factors measured post mortem to measured atherosclerosis in these arteries. 1, 2 In the Coronary Artery Risk Development in Young Adults (CARDIA) study, the PDAY risk score measured at ages 18 to 30 years and 15-year change in the score predicted the likelihood of coronary artery calcium (CAC) assessed by computed tomography (CT) scan 15 years later. 3 In the Cardiovascular Risk in Young Finns study, the coronary PDAY score measured in adolescence and the change in score predicted future carotid intima media thickness measured in young adulthood. 4 These results support similar results from the Bogalusa Heart Study, the Muscatine study, and additional analyses from the CARDIA and Young Finns studies that have shown the importance of risk factor levels in early life in the development of atherosclerosis later in adulthood. [5] [6] [7] [8] 
Clinical Perspective on p 146
During the CARDIA year 25 examination, chest and abdominal CT scans were performed. We sought to determine whether the coronary artery PDAY score predicted CAC 25 years in the future and compare this prediction with our previous work. 3 We also explored whether the abdominal aortic PDAY score, not previously evaluated in living individuals, predicted the development of abdominal aortic calcification (AAC). We hypothesized that scores measured many years before CAC and AAC measurement would perform better than scores measured closer to obtaining the CT scan.
Methods
The PDAY scores were developed from modeling relationships among risk factors measured postmortem and atherosclerosis in the coronary arteries found in 15-to 34-year-old people who died of external causes: accidents, suicide, or homicide. 1 The PDAY risk scores were scaled so that a 1-point increase in score was associated with the odds ratio for an increase in advanced atherosclerotic lesions that would develop with 1 year of aging. The point value for each of the risk factors for the coronary artery and abdominal aortic scores are shown in Table 1 . Note that the risk values for the abdominal and coronary scores are different.
The CARDIA study recruited 5115 generally healthy black and white men and women aged 18 to 30 years in 1985 to 1986 at 4 sites: Birmingham, AL; Chicago, IL; Minneapolis, MN; and Oakland, CA, with a long-term goal of studying cardiovascular risk evolution from young adulthood into middle age. 3 Examinations every 2 to 5 years have been conducted over the subsequent 25 years. With regard to this analysis, data were used from the baseline, year 5, year 10, year 15, year 20, and year 25 examinations including chest CT scans performed in years 15, 20, and 25 and an abdominal CT scan performed in year 25. Institutional review board approval was obtained from participants at each examination.
The sample for this study (n=3008) did not include those who had died or did not attend the year 25 examination (n=1617), were missing year 25 CAC or AAC (n=381), or were missing data necessary for the calculation of the coronary or abdominal aorta PDAY scores at year 0 or year 25 (n=109). Those included were less likely to be male and black, had lower blood pressure, smoked less, and were older 9 (data not shown).
Measurement of CAC and AAC Using CT
ECG-gated scans of the heart used to determine CAC were performed using a standard protocol that has been described in detail. 10 At years 15 and 20, 2 sequential heart scans were obtained and their scores averaged, whereas a single scan was obtained at year 25. Image analysis was performed at a central reading center (Wake Forest University Health Sciences, Winston-Salem, NC). Trained technicians measured CAC on a workstation with Food and Drug Administration-approved calcium scoring software (Aquarius Workstation, TeraRecon, Foster City, CA).The Agatston score, corrected for slice thickness with a minimum lesion size of 4 adjacent pixels (minimum area of 1.87 mm 2 ) and attenuation threshold of ≥130 Hounsfield units, is reported. 11 For analyses comparing the absence with the presence of CAC or AAC, any CAC or AAC was considered a positive result. The previously reported year 15 CAC scores (read at a different site) were reanalyzed using the year 20 and 25 software and readers to ensure longitudinal standardization. A physician adjudicated the CAC scores, under the following conditions: discordant for CAC presence within paired scans at years 15 and 20, a score change of >200, a change in CAC status from positive to negative, or a potential surgical intervention (pacemaker, valve replacement, intracoronary stent, coronary bypass surgery). In those with confirmed intracoronary stents (n=36: 2 at year 15, 9 at year 20, and 25 at year 25), the stented area was excluded from the vessel score, 100 Agatston units were added to account for potential obscured calcifications, and the remaining vessels were scored. In participants with coronary artery bypass grafting (n=7: 3 at year 20 and 4 at year 25), only the native coronary arteries were scored for calcifications. The accuracy, comparability, reproducibility, and robustness of the calcium score using electron beam, helical, and multidetector CT systems have previously been published. [12] [13] [14] At year 25 only, AAC was measured in the distal abdominal aorta in a 60-mm segment centered at the aortic bifurcation. 15, 16 At year 25, the interclass correlation coefficient for interreader comparisons was 0.999 for both CAC and AAC, and intra-and interreader error were5.6% and 7.0% for CAC, and 6.4% and 8.6% for AAC, respectively, in 156 scans that were blinded and reevaluated.
For score calculation, height and weight were measured in light clothing and body mass index was calculated. Blood pressure was measured 3 times after a 5-minute rest with the last 2 values averaged. Hypertension was defined as blood pressure >130/85 mm Hg or taking antihypertensive medication. Tobacco use was assessed by questionnaire. Total cholesterol and high-density lipoprotein cholesterol were measured by enzymatic techniques and non-high-density lipoprotein cholesterol was calculated as the difference between total and high-density lipoprotein cholesterol. Diabetes mellitus status was determined by using American Diabetes Association criteria; history of hypoglycemic medication use (all examinations), fasting blood 17 Coronary and abdominal aorta PDAY scores were computed for the cohort at each of the CARDIA examinations of interest: years 0, 5, 10, 15, 20, and 25. Because CARDIA participants were outside the 15-to 34-year age range at the year 5, 10, 15, 20, and 25 examinations, age was not used in the computation of the coronary or abdominal PDAY risk scores. Rather, age at CAC assessment was adjusted for in analyses. Because race was not significant in the PDAY analysis, race was not considered as an independent variable in analyses. Descriptive statistics for PDAY risk scores were tabulated by examination year. Four analyses were conducted. First, for each PDAY score, logistic regression adjusting for age at CAC measurement was used to assess associations with year 25 CAC by computing odds ratios and 95% confidence intervals. Discrimination was assessed with c-statistics, and calibration was tested with the Hosmer-Lemeshow test. C-statistics were compared using the test for correlated ROC curves by DeLong et al. 18 Second, to examine whether change in risk score from year 0 to year 25 improved model fit, we assessed 2 additional models, both containing the year 25 -year 0 PDAY score difference, but one then containing the year 0 PDAY score and the other containing the year 25 PDAY score.
Third, to determine the impact of early adulthood risk on midlife atherosclerosis, we assessed the association of year 0 PDAY score, when participants were 18 to 30 years of age, with the likelihood of having CAC at 40 to 45 years of age. For this analysis, we used the CT scan (year 15, 20, or 25) that corresponded to when the participant was aged 40 to 45 years.
Fourth, to determine the impact of early life risk and change in risk on incident/change in CAC, we divided the cohort with CAC assessment at years 15 and 25 into approximate tertiles based on initial PDAY coronary artery score and then within each tertile created tertiles of risk change. This created 9 groups to assess the likelihood of CAC progression. The group with low baseline risk and no increase in risk was used for comparisons. Of 3008 participants, 2320 had CAC measured at both year 15 and year 25, and 650 of these had CAC progression defined as any new CAC at year 25 or, if any CAC was present at year 15, then at least 20 Agatston units greater was present at year 25.
Results
Gender-specific risk factor distributions and PDAY scores by examination year are presented in Table 2 . Mean age-independent PDAY scores increased from CARDIA year 0 to year 25 (coronary, 1.80-4.95; abdomen, 1.88-3.18). Median PDAY scores are also presented in Table 2 ; these increased at each examination. For men, the median coronary PDAY score increased from 2 at year 0 to 6 at year 25, and the median abdominal aorta PDAY score increased from 1 to 3 over the same interval. For women, the median coronary PDAY score increased from 0 at baseline to 2 at year 25, and the median abdominal aorta PDAY score increased from 2 to 4 over the same interval. Table 3 provides the prevalence of CAC at years 15, 20, and 25 by level of CAC categories. Prevalence of any CAC increased from 9.6% at year 15 to 28.1% at year 25. Baseline coronary PDAY score was higher with greater intensity of CAC. The prevalence of any AAC was 52.8% at year 25. AAC was only measured at year 25, and intensity is shown in tertiles ( Table 4 ). The baseline abdominal aorta PDAY score was also higher with greater intensity of AAC.
Odds ratios for the presence of CAC at year 25 according to each 1 point higher coronary PDAY score calculated at each 5-year examination, and the corresponding c-statistics, as well, are shown in Figure. The highest odds ratio (OR), 1.29 (95% confidence interval [CI], 1.25-1.33), was noted at baseline, and the lowest, at year 25, 1.12 (95% CI, 1.11-1.14). The Hosmer-Lemeshow test was not significant at each examination (P>0.09) with the exception of year 20 (P=0.03), indicating acceptable goodness-of-fit for most examinations. The c-statistics for examination years 0 to 25 varied from 0.705 at year 25 to 0.740 at year 5. The c-statistics computed for years 0 and 25 were significantly different (P=0.004).
Odds ratios for the presence of AAC at year 25 according to each 1 point higher abdominal aortic PDAY score are also shown in Figure. PDAY scores calculated using data from years 5 and 10 (OR, 1.32 and1.33) had higher ORs than those based on year 25 (OR, 1.22; 95% CI, 1.19-1.26). The Hosmer-Lemeshow test indicated lack of goodness-offit at year 0 (P=0.002) and year 20 (P=0.02), but acceptable goodness-of-fit at all other examinations (P≥0.12). C-statistics were generally equivalent across all examination years with somewhat lower values than for the coronary scores (Figure) .
For both CAC and AAC prediction, we examined whether change in risk from year 0 to year 25 improved model fit ( Table 5 ). Models were constructed that included baseline PDAY score and change in score over 25 years. The OR for CAC at year 25 for each 1 point higher PDAY score at baseline was 1.31 (95% CI, 1.27-1.35) and for change in score was 1.07 (95% CI, 1.05-1.09) for each 1-point increase in score. The c-statistic increased from 0.731 (0.711-0.751) for baseline PDAY score only to 0.745 (0.725-0.764) when change in score was included. For AAC, the 25-year change in score was statistically significant. The OR for ACC at year 25 for each 1 point higher score was 1.40 (95% CI, 1.34-1.46) at baseline and 1.16 (95% CI, 1.13-1.20) for 25-year change, with the c-statistic increasing from 0.665 (0.646-0.684) to 0.693 (0.674-0.712) with inclusion of change in risk. Analyses were repeated using the year 25 scores and change from baseline; the change in risk terms had a similar significance level as above (data not shown). Thus, change in risk, either favorably or unfavorably, was important in determining future atherosclerosis but the ORs were lower for change in score.
By using CAC data from the year 15, 20, and 25 examinations, we were able to examine the performance of the coronary PDAY risk score measured at 18 to 30 years of age for the prediction of CAC at 40 to 45 years of age. The OR for the presence of CAC at 40 to 45 years of age with each 1 point higher score was 1.22 (95% CI, 1.18-1.27) when measured at 18 to 30 years of age and 1.14 (95% CI, 1.11-1.16) when measured at 40 to 45 years of age. The c-statistic calculated at baseline was 0.704 (0.674-0.734) and was 0.697 (0.668-0.725) when calculated at 40 to 45 years of age. These results are consistent with the results discussed above.
Baseline PDAY score determined change in CAC between examination years 15 and 25 (Table 6 ). For each tertile of baseline PDAY score, ORs for change in CAC increased as PDAY score increased. For those in the lowest tertile of PDAY score, the increase in risk during the study predicted higher likelihood of change in CAC. Those with baseline PDAY risk score of 2 or higher were much more likely to progress.
Discussion
The relationship of risk factors measured in adolescence or early adulthood to both atherosclerosis and subclinical atherosclerosis measured in adults aged 30 to 45 years has been established in several cohort studies from the United States, Finland, and Australia and in black and white men and women. 3, [5] [6] [7] 19, 20 Showing a strong association of the PDAY risk score measured at age 18 to 30 years to the presence and intensity of subclinical coronary atherosclerosis measured 25 years later extends the relationship of risk early in life to middle age, a time when clinical events are likely to occur. Furthermore, for the first time, we have shown a significant relationship between the PDAY risk score for abdominal atherosclerosis measured in early adulthood to subclinical atherosclerosis measured in middle age. For the coronary arteries, PDAY risk measured at 18 to 30 years of age strongly predicts CAC, a noninvasive measure of advanced atheroma. Change in risk improves the estimate. Increase in CAC also appears to be driven by baseline risk and change in risk over time. For the abdominal aorta, risk measured at 28 to 40 years of age predicts AAC best and, again, change in risk adds information to risk prediction. These data add strength to the observational evidence that early intervention to prevent atherosclerosis may have an important impact on atherosclerotic vascular disease prevention.
By showing that risk measured up to 25 years before CAC assessment predicts CAC, our data suggest that CAC may be a measure of cumulative risk exposure. CAC reclassifies risk for atherosclerotic and other forms of heart disease in older individuals. 21, 22 These estimates are based on combining, in prediction models, risk factors measured at the time of subclinical atherosclerosis imaging to measures of subclinical atherosclerosis. If CAC represents the integrated risk burden over the individual's lifetime history of exposure, our data suggest that risk reclassification provided by CAC score likely encodes the cumulative exposure to cardiovascular disease risk over the lifetime. This cumulative risk encoded in the presence and amount of CAC is not captured by point estimates of cardiovascular disease risk factors measured in middle adult life and is, in fact, better predicted by risk factors measured in early adulthood.
That change in risk adds information to CAC and AAC prediction models is important for prevention strategies. Lowering risk from 18 to 30 years of age lowers the likelihood of future atherosclerosis while increasing risk increases likelihood. These results are consistent with observations from the Cardiovascular Risk in Young Finns Study where carotid intima media thickness was similar in individuals who were obese in adolescence and normal weight as adults to that of individuals who were lean throughout the study. 19 This study is consistent with previous reports from the CARDIA study and the Cardiovascular Risk in Young Finns study where risk measured at 18 to 30 years of age strongly predicts coronary calcium and carotid intima media thickness measured 15 years later. 3, 4, 8 Analyses of risk factor trajectories for blood pressure and lipids from CARDIA have shown that both baseline risk and the burden of risk over time are important in predicting intermediate outcomes such as CAC and left ventricular dysfunction assessed by echocardiography. [23] [24] [25] In these risk trajectory models, baseline blood pressure or obesity risk carries more weight than risk exposure over time.
The PDAY abdominal score did not predict AAC in the future, and the coronary score, as well. This may be because the risk factors for AAC have different weights in the prediction algorithm than for CAC, with tobacco use being the most important risk factor for AAC. Tobacco use, either because of addiction (and unvarying risk) or because tobacco use causes irreversible abdominal aortic injury early in life, may be part of the reason. Our results are consistent with the high attributable risk of tobacco use for abdominal aortic aneurysms. 26 There are 2 major limitations to this article. First, CAC and AAC measure advanced atherosclerosis and are an estimate, but not a direct measure, of total atherosclerosis burden. Thus, these assessments lack precision. Second, the PDAY risk score reflects postmortem risk measurements. For some risk factors, such as blood pressure, only categorical classification of hypertension versus normotension were provided. Socioeconomic status and family history cannot be included in the score. We have previously shown that risk estimated based on lipid measures underestimates risk associations because of concentration changes induced by resuscitation and other postmortem changes. 27 For these reasons, we believe that the risk estimates in this study underestimate the ability to predict future atherosclerotic burden.
We have previously suggested an alternative model for preventing atherosclerosis, resetting the vascular clock by intervening earlier in the course of atherosclerosis at a time when progression of vascular lesions may be impeded or more reversible. 28 Controlling risk factors in youth would be most effective in preventing atherosclerotic heart disease by retarding the progression of lesions to advanced stages. 29 Atherosclerosis begins to progress from the teen age years in association with risk scores, and progression proceeds dramatically in the third and fourth decades of life. Clinical trials suggest better event reduction in those with high lifetime rather than proximate risk. 30 Animal models of atherosclerosis confirm the opportunity for atherosclerosis regression with treatment. 31 Our findings may help with a 2-pronged approach to the atherosclerosis prevention effort: population-based risk assessment for primordial prevention in the population at large and identification of those at highest risk for early development of advanced lesions with treatment earlier in the course of atherosclerosis to achieve regression. 32
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